Scholarlink

Purpose <p>To investigate if the use of intravenous dexamethasone prior to surgery is effective in reducing hospitalisation time for patients with ankle oedema.</p> Methods <p>A prospective cohort study was conducted on consecutive patients with a fresh ankle dislocated fracture. Indications for starting treatment with dexamethasone 8&#xa0;mg was single blinded for patients randomly selected. A total of 62 patients were included of which 39 were females and 23 males with an age range of 20–86&#xa0;years (mean 53.6). Patients who were not treated with dexamethasone were designated to a control group. Treatment with dexamethasone was started soon after admission for a maximum period of three days. Subsequently, the period of hospital stay was calculated.</p> Results <p>30 patients received dexamethasone intravenous every 6&#xa0;h and 32 patients were placebo, included in this study. Average hospitalisation time with dislocated ankle fracture before operation with dexamethasone treatment was reduced from 6.5 to 3&#xa0;days using the U Mann–Whitney test/ two –tailed test (U = 627.500, p = 0.033). Standard deviation for Hospitalisation time before operation in the DEXA group was 2.490 while, the placebo group was 5.067, which was statistically significant. None of the patients treated with dexamethasone developed wound infection.</p> Conclusion <p>The use of intravenous dexamethasone prior to dislocated ankle fracture surgery can significantly reduce oedema, wound infection and hospitalisation period.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The Use of Intravenous Dexamethasone in Preventing Severe Ankle Oedema to Reduce Hospitalisation Length of Patients with Dislocated Ankle Fracture

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月21日

查看全文
  • Gharaibeh Ahmad,
  • Štefan Štolfa,
  • Mahmoud M. Gharaibeh

摘要

Purpose

To investigate if the use of intravenous dexamethasone prior to surgery is effective in reducing hospitalisation time for patients with ankle oedema.

Methods

A prospective cohort study was conducted on consecutive patients with a fresh ankle dislocated fracture. Indications for starting treatment with dexamethasone 8 mg was single blinded for patients randomly selected. A total of 62 patients were included of which 39 were females and 23 males with an age range of 20–86 years (mean 53.6). Patients who were not treated with dexamethasone were designated to a control group. Treatment with dexamethasone was started soon after admission for a maximum period of three days. Subsequently, the period of hospital stay was calculated.

Results

30 patients received dexamethasone intravenous every 6 h and 32 patients were placebo, included in this study. Average hospitalisation time with dislocated ankle fracture before operation with dexamethasone treatment was reduced from 6.5 to 3 days using the U Mann–Whitney test/ two –tailed test (U = 627.500, p = 0.033). Standard deviation for Hospitalisation time before operation in the DEXA group was 2.490 while, the placebo group was 5.067, which was statistically significant. None of the patients treated with dexamethasone developed wound infection.

Conclusion

The use of intravenous dexamethasone prior to dislocated ankle fracture surgery can significantly reduce oedema, wound infection and hospitalisation period.